Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
Alpha IVF earnings are projected to grow 18.9% in FY26, 20% in FY27 and 14.7% in FY28, supported by new centres, rising Chinese patient demand and a rebound in Singapore operations.
TA Securities Holdings Bhd has initiated coverage on Alpha IVF Group Bhd with a ‘Buy’ call and a target price of 36 sen, implying a potential upside of 24.5% from its last traded price of 29 sen.
According to TA Securities, Alpha IVF Group Berhad’s growth trajectory is expected to accelerate following its impressive achievement of an 80% pregnancy success rate to date compared to global benchmark of around 65%.
